Global Sensory Organ Partnering 2012-2018: Deals and Contract Documents for 60+ Sensory Organ Deals

Dublin, March 21, 2018 -- The "Global Sensory Organ Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Global Sensory Organ Partnering 2012 to 2018 provides the full collection of Sensory Organ disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Sensory Organ disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sensory Organ deals.

The report presents financial deal terms values for Sensory Organ deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

In addition, a comprehensive appendix is provided with each report of all Sensory Organ partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Sensory Organ technologies and products.

Report scope

Global Sensory Organ Partnering 2012 to 2018 includes:

• Trends in Sensory Organ dealmaking in the biopharma industry since 2012
• Analysis of Sensory Organ deal structure
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of Sensory Organ deal contract documents
• Comprehensive access to over 3500 Sensory Organ deal records
• The leading Sensory Organ deals by value since 2012
• Most active Sensory Organ dealmakers since 2012

Available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication
  

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Sensory Organ dealmaking

2.1. Introduction
2.2. Sensory Organ partnering over the years
2.3. Sensory Organ partnering by deal type
2.4. Sensory Organ partnering by industry sector
2.5. Sensory Organ partnering by stage of development
2.6. Sensory Organ partnering by technology type
2.7. Sensory Organ partnering by therapeutic indication

Chapter 3 - Financial deal terms for Sensory Organ partnering

3.1. Introduction
3.2. Disclosed financials terms for Sensory Organ partnering
3.3. Sensory Organ partnering headline values
3.4. Sensory Organ deal upfront payments
3.5. Sensory Organ deal milestone payments
3.6. Sensory Organ royalty rates

Chapter 4 - Leading Sensory Organ deals and dealmakers

4.1. Introduction
4.2. Most active in Sensory Organ partnering
4.3. List of most active dealmakers in Sensory Organ
4.4. Top Sensory Organ deals by value

Chapter 5 - Sensory Organ contract document directory

5.1. Introduction
5.2. Sensory Organ partnering deals where contract document available

Chapter 6 - Sensory Organ dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Sensory Organ therapeutic target

Appendices

Appendix 1 - Directory of Sensory Organ deals by company A-Z 2012 to 2018
Appendix 2 - Directory of Sensory Organ deals by deal type 2012 to 2018
Appendix 3 - Directory of Sensory Organ deals by stage of development 2012 to 2018
Appendix 4 - Directory of Sensory Organ deals by technology type 2012 to 2018

For more information about this report visit https://www.researchandmarkets.com/research/kphmt9/global_sensory?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Pharmaceuticals